Industry
GLP-1 & Weight Loss Telehealth
Technology platforms for GLP-1 and medical weight loss telehealth programs — intake, prescribing workflows, monitoring, and patient retention.
Who we build for
Built for your team.
Founder or VP Operations at a DTC GLP-1 telehealth company building initial infrastructure or scaling past a DIY/no-code MVP.
We need an intake-to-prescription workflow that's fast, compliant, and doesn't require a human to touch every case.
GLP-1 patients need weekly check-ins — we need automated touchpoints that don't overwhelm our staff.
FDA and FTC are watching this space closely — we need to be conservative on claims and airtight on compliance.
Pains we solve
Your priorities — addressed.
We need an intake-to-prescription workflow that's fast, compliant, and doesn't require a human to touch every case.
GLP-1 patients need weekly check-ins — we need automated touchpoints that don't overwhelm our staff.
FDA and FTC are watching this space closely — we need to be conservative on claims and airtight on compliance.
Our compounding pharmacy partner relationship needs a data bridge — we can't be manually sending prescriptions.
What we build
Software built for GLP-1 & Weight Loss Telehealth.
Custom Telehealth Platforms
Video visit infrastructure, scheduling, and async care workflows.
Healthcare AI Automations
Workflow automation — intake, reminders, referrals, prior auth.
Integrations Engineering
EHR, LIS, PMS, and third-party API connections built for healthcare.
HIPAA Cloud Infrastructure
AWS/GCP infrastructure designed for PHI and compliance-ready deployments.
Regulatory & compliance landscape
Built with compliance as a first-class requirement.
HIPAA: covered entity. BAA with all vendors. FDA: semaglutide and tirzepatide are FDA-approved GLP-1 agonists. Compounded versions are in a heavily evolving enforcement landscape — FDA has taken action on compounded semaglutide; regulatory status is actively changing. Do not make blanket claims about compounded GLP-1 availability; website copy must be reviewed for accuracy at launch. DEA: GLP-1 medications themselves are not controlled substances; phentermine (Schedule IV) is — those workflows require DEA compliance. FTC: weight loss claims are one of FTC's most closely watched categories. Testimonials require typical results disclosure.
Client work
Results in the field.
GLP-1 telehealth startup: intake-to-prescription platform
Case study coming soon
Medical weight loss program: automated check-in and retention system
Case study coming soon
Frequently asked
Common questions.
Deep dives
Capability + GLP-1 & Weight Loss Telehealth.
Let's talk about GLP-1 & Weight Loss Telehealth.
Every industry is different. Schedule a conversation to explore how we can build technology that works for your practice or business.